Skip to main content
. 2017 Jun 16;22(6):1002. doi: 10.3390/molecules22061002

Table 6.

Oviposition inhibition activity of isobutyrylshikonin and isovalerylshikonin on Tetranychus urticae females.

Dose (μg·cm−2) Isobutyrylshikonin Isovalerylshikonin
Eggs/Female ± SD a Inhibition Oviposition (% ± SD) b ED50 (CI95) c ED90 (CI95) c Chi d Eggs/Female ± SD a Inhibition Oviposition (% ± SD) b ED50 (CI95) c ED90 (CI95) c Chi d
13.5 2.6 ± 0.3 91.1 ± 3.2 2.71
(1.79–3.96)
9.31
(8.97–15.56)
2.524 0.3 ± 0.1 98.8 ± 2.1 1.15
(0.02–1.29)
2.75
(2.38–3.34)
2.253
6.8 4.3 ± 1.1 85.9 ± 5.5 0.9 ± 0.2 97.0 ± 3.5
3.4 11.2 ± 0.9 62.7 ± 4.3 2.5 ± 0.8 91.7 ± 2.8
1.7 19.3 ± 1.1 36.1 ± 4.6 7.5 ± 0.8 75.1 ± 3.1
0.8 28.4 ± 2.1 5.4 ± 0.9 21.6 ± 1.8 28.1 ± 1.7
Control 30.1 ± 4.5 - 30.1 ± 4.5 -

a Average number of eggs laid per female ± standard deviation (S.D.); b Mean inhibition of oviposition (in %) in comparison with the control ± standard deviation; c Effective dose ED50 (ED90) in μg·cm−2 causing 50% (90%) inhibition of egg laying by females T. urticae, compared with untreated control; CI95 = 95% confidence intervals, the activity is considered significantly different when the 95% CI fail to overlap; d Chi-square value, not significant at p > 0.05 level.